Skip to content

Impact of COVID-19 on tuberculosis prevention and control in Brazil: a look at social policies, the disease situation and new technologies (CoV-TB Project)

Impact of COVID-19 on the prevention and control of Tuberculosis in Brazil: Analysis of social protection policies, the epidemiological situation and technological incorporation (CoV-TB Project)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-9pb4qsq
Enrollment
Unknown
Registered
2024-08-12
Start date
2024-08-15
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tuberculosis

Interventions

This is a three-arm, multicenter, non-randomized clinical trial. The sample will include 100 participants. The study aims to implement a system for asynchronous supervision via telemonitoring of direc

Sponsors

Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Lead Sponsor
Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: New cases of tuberculosis. Over 18 years old. No gender criteria. Own a mobile phone (intervention group). Health professionals responsible for Directly Observed Treatment (DOT) and/or monitoring of people with tuberculosis. Unit managers (Primary Health Care (PHC) coordinators and/or tuberculosis program coordinators of the health units in the municipalities, previously selected)

Exclusion criteria

Exclusion criteria: Resistant Tuberculosis. Professionals and/or managers who have been in the position or working with tuberculosis for less than 6 months. Unavailability of individual or family cell phone

Design outcomes

Primary

MeasureTime frame
The primary outcome assessed in the study will be adherence to Tuberculosis treatment according to the participants' percentage of treatment completion according to each treatment strategy.

Secondary

MeasureTime frame
As secondary outcomes of the study, we have costs related to treatment from the perspective of patients and health professionals and usability of VDOT also from the perspective of patients and professionals. In addition, issues of the structure, process and result triad will be evaluated as a secondary outcome.

Countries

Brazil

Contacts

Public ContactRicardo Arcêncio

Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo

ricardo@eerp.usp.br+55 (16) 33154408

Outcome results

None listed

Source: REBEC (via WHO ICTRP)